Abstract
Five TNF inhibitors (TNFi) (infliximab, etanercept, adalimumab and golimumab) have been proven highly efficacious in reducing signs and symptoms of ankylosing spondylitis (AS) and are approved for this indication. However,...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
